All Relations between Autism Spectrum Disorder and cannabinoids

Publication Sentence Publish Date Extraction Date Species
Adi Aran, Dalit Cayam Ran. Cannabinoid treatment for the symptoms of autism spectrum disorder. Expert opinion on emerging drugs. 2024-01-16. PMID:38226593. cannabinoid treatment for the symptoms of autism spectrum disorder. 2024-01-16 2024-01-18 Not clear
Helena K Kim, Vanessa F Gonçalves, Muhammad I Husain, Daniel J Müller, Benoit H Mulsant, Gwyneth Zai, Stefan Kloibe. Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia. Psychiatry research. vol 330. 2023-11-04. PMID:37924773. cross-disorder gwas meta-analysis of endocannabinoid dna variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia. 2023-11-04 2023-11-08 Not clear
Matthew N Hill, Margaret Haney, Cecilia J Hillard, Debra S Karhson, Haley A Vecchiarell. The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. Psychological medicine. 2023-09-06. PMID:37671673. herein we review the current body of literature regarding the various pharmacological tools that have been developed to target the endocannabinoid system, their impact in preclinical models of psychiatric illness and the recent data emerging of their utilization in clinical trials for psychiatric illnesses, with a specific focus on substance use disorders, trauma-related disorders, and autism. 2023-09-06 2023-10-07 Not clear
Adi Aran, Moria Harel, Aminadav Ovadia, Shulamit Shalgy, Dalit Cayam-Ran. Mediators of Placebo Response to Cannabinoid Treatment in Children with Autism Spectrum Disorder. Journal of clinical medicine. vol 12. issue 9. 2023-05-14. PMID:37176538. mediators of placebo response to cannabinoid treatment in children with autism spectrum disorder. 2023-05-14 2023-08-14 human
Rick Wilhiam de Camargo, Linério Ribeiro de Novais Júnior, Larissa Mendes da Silva, Vicente Meneguzzo, Guilherme Cabreira Daros, Marina Goulart da Silva, Rafael Mariano de Bitencour. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacology, biochemistry, and behavior. 2022-11-15. PMID:36379443. implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: a literature review. 2022-11-15 2023-08-14 Not clear
Riccardo Bortoletto, Marco Colizz. Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis. Healthcare (Basel, Switzerland). vol 10. issue 8. 2022-08-26. PMID:36011210. thus, findings support a developmental trajectory between autism and psychosis, as per endocannabinoid system modulation. 2022-08-26 2023-08-14 Not clear
Aviad Schnapp, Moria Harel, Dalit Cayam-Rand, Hanoch Cassuto, Lola Polyansky, Adi Ara. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines. vol 10. issue 7. 2022-07-27. PMID:35884990. a placebo-controlled trial of cannabinoid treatment for disruptive behavior in children and adolescents with autism spectrum disorder: effects on sleep parameters as measured by the cshq. 2022-07-27 2023-08-14 human
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health. vol 19. issue 9. 2022-05-14. PMID:35565034. in this regard, the endocannabinoid system has been suggested to modulate neural circuits during the early stage of neurodevelopment, with implications for both autism and psychosis. 2022-05-14 2023-08-13 human
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health. vol 19. issue 9. 2022-05-14. PMID:35565034. here, we systematically review all human and animal studies examining the endocannabinoid system and its biobehavioral correlates in the association between autism and psychosis. 2022-05-14 2023-08-13 human
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health. vol 19. issue 9. 2022-05-14. PMID:35565034. studies indicate overlapping biobehavioral aberrancies between autism and schizophrenia, subject to correction by modulation of the endocannabinoid system. 2022-05-14 2023-08-13 human
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health. vol 19. issue 9. 2022-05-14. PMID:35565034. interestingly, a developmental and transgenerational trajectory between autism and schizophrenia is supported by evidence that exogenous alteration of the endocannabinoid system promotes progression to inheritable psychosis phenotypes in the context of biobehavioral autism vulnerability. 2022-05-14 2023-08-13 human
Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Sagnik Bhattacharyya, Matteo Balestrier. The Autism-Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System. International journal of environmental research and public health. vol 19. issue 9. 2022-05-14. PMID:35565034. several clinical implications follow from evidence of a developmental continuum between autism and psychosis as a function of the endocannabinoid system dysregulation. 2022-05-14 2023-08-13 human
Mariana Babayeva, Haregewein Assefa, Paramita Basu, Zvi Loew. Autism and associated disorders: cannabis as a potential therapy. Frontiers in bioscience (Elite edition). vol 14. issue 1. 2022-03-23. PMID:35320905. therefore, the endocannabinoid system represents a potential target for the development of a novel autism therapy. 2022-03-23 2023-08-13 Not clear
Michelle De Pol, Nathan J Koll. Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies. Psychiatry research. vol 306. 2021-12-07. PMID:34775294. endocannabinoid markers in autism spectrum disorder: a scoping review of human studies. 2021-12-07 2023-08-13 human
Susanna Pietropaolo, Giovanni Marsican. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models. Neuroscience and biobehavioral reviews. 2021-11-30. PMID:34813825. the role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: lessons from behavioral studies on mouse models. 2021-11-30 2023-08-13 mouse
Aviv Amirav, Benny Neumark, Ksenia J Margolin Eren, Alexander B Fialkov, Noam Ta. Cannabis and its cannabinoids analysis by gas chromatography-mass spectrometry with Cold EI. Journal of mass spectrometry : JMS. vol 56. issue 6. 2021-11-15. PMID:33955098. finally, cannabis drugs such as ep-1 used in israel for treatment of epilepsy and for children with autism spectrum disorder (asd) were analyzed for their full cannabinoids content for learning on the entourage effect and for drug activity optimization. 2021-11-15 2023-08-13 Not clear
Tangfeng Su, Yu Yan, Qiang Li, Jiacai Ye, Lei Pe. Endocannabinoid System Unlocks the Puzzle of Autism Treatment Frontiers in psychiatry. vol 12. 2021-11-10. PMID:34744824. endocannabinoid system unlocks the puzzle of autism treatment autism spectrum disorder (asd) is a serious neurodevelopmental disorder and characterized by early childhood-onset impairments in social interaction and communication, restricted and repetitive patterns of behavior or interests. 2021-11-10 2023-08-13 Not clear
Mingyang Zou, Yu Liu, Shu Xie, Luxi Wang, Dexin Li, Ling Li, Feng Wang, Yujue Zhang, Wei Xia, Caihong Sun, Lijie W. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open biology. vol 11. issue 2. 2021-10-14. PMID:33529552. alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. 2021-10-14 2023-08-13 rat
Mingyang Zou, Yu Liu, Shu Xie, Luxi Wang, Dexin Li, Ling Li, Feng Wang, Yujue Zhang, Wei Xia, Caihong Sun, Lijie W. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder. Open biology. vol 11. issue 2. 2021-10-14. PMID:33529552. we examined three major components of the ecb system-endogenous cannabinoids, their receptors and associated enzymes-in asd children as well as in the valproic acid (vpa) induced animal model in autism. 2021-10-14 2023-08-13 rat
William Fyke, Marika Premoli, Victor Echeverry Alzate, José A López-Moreno, Valerie Lemaire-Mayo, Wim E Crusio, Giovanni Marsicano, Markus Wöhr, Susanna Pietropaol. Communication and social interaction in the cannabinoid-type 1 receptor null mouse: Implications for autism spectrum disorder. Autism research : official journal of the International Society for Autism Research. vol 14. issue 9. 2021-09-27. PMID:34173729. clinical and preclinical findings have suggested a role of the endocannabinoid system (ecs) in the etiopathology of autism spectrum disorder (asd). 2021-09-27 2023-08-13 mouse